Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in CYTOMX THERAPEUTICS INC.
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 189,400 shares of CTMX (CYTOMX THERAPEUTICS INC.), worth $890,180 as of 2026-Q1. This is a new position. CTMX represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$890,180
Current Shares
189,400
Total Value Change
$0
Total Shares Change
0
Other major holders of CTMX: FMR LLC, BNP PARIBAS FINANCIAL MARKETS
New |
| 189,400 |
- |
| $890,180 |
| 0.0% |
| $4.81 |
34 |